Clinical Trials
40 trialsE-FACTOR
Centre Leon Berard
LUTACT
University of California, San Francisco
The Use of Nanoparticles to Guide the Surgical Treatment of Prostate Cancer
Memorial Sloan Kettering Cancer Center
AdOTAC
Institut de Cancérologie de Lorraine
Mechanisms of Resistance to PSMA Radioligand Therapy
University of California, San Francisco
Characterizing the Genomic Landscape of Prostate Cancer in Native American Populations (NAT-Geno)
University of Oklahoma
MiR_CPMRC
University Hospital, Tours
Cancer DNA Detection in Blood and Urine
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
CHEMOPROST
Institut Bergonié
HOPE
Institut Curie
FOR46 in Combination With Enzalutamide in Patients With Metastatic Castration Resistant Prostate Cancer
University of California, San Francisco
Imaging of Solid Tumors Using 18F-TRX
University of California, San Francisco
EPIDROP
University Hospital, Montpellier
Ultralow Dose PET Imaging for PSMA Expression
Nuclear Imaging Institute
Associations Between Chemotherapy-Induced Nausea in Patients With Genitourinary, Sarcoma or Melanoma Cancers and Changes in Gut Microbiome: Potential for Precision Therapeutics
Mayo Clinic
Application of a Novel Biomarker Based on Plasma cfDNA Assay in the Early Diagnosis of Prostate Cancer
Shanghai Changzheng Hospital
The Effect of IBD Flares on Serum PSA
Northwestern University
LUTRAC
Erasmus Medical Center
PROMECI
University Hospital, Tours
CHANGE
Hospices Civils de Lyon
Evaluation of Molecular Forms of PSA and Human Kallikrein 2 in a Cohort of Patients With Locally Resected Prostate Cancer But Biochemical Recurrence
Memorial Sloan Kettering Cancer Center
IRSTB030
Istituto Romagnolo per lo Studio dei Tumori Dino Amadori IRST S.r.l. IRCCS
Characterize Tumor Hypoxia by Magnetic Resonance Imaging
Wake Forest University Health Sciences
AndroCan
Hopital Foch
PROLIPSY
University Hospital, Montpellier
A Pilot Study to Assess the Immunogenicity of Candidate PSA Peptides for a Prostate Cancer Vaccine
University of Arkansas
ONCOPRO
Hospices Civils de Lyon
NEUROTAX
University Hospital, Tours
The Immunodynamic Effect of Radiotherapy in Prostate Cancer Patients.
Regina Elena Cancer Institute
PROMPT
Radboud University Medical Center
Circulating Tumor Cells in Prostate Cancer Patients
University of Texas Southwestern Medical Center
Investigating and Characterizing the Immune Response to Prostate Cancer
NYU Langone Health
NKPROSTATE
Institut Paoli-Calmettes
Genetic Biomarker Discovery for Metastatic Prostate Cancer
Mayo Clinic
Low-Fat Fish Oil Diet for Prostate Cancer Prevention
Jonsson Comprehensive Cancer Center
[18F] Dihydro-testosterone Pet and MR Imaging In Patients With Localized Prostate Cancer
Memorial Sloan Kettering Cancer Center
Establishment and Clinical Assessment of a Prostate Cancer (PCa) Risk Model Based on the Updated Circulating Tumor Cell (CTC) Detection Technique
Xinhua Hospital, Shanghai Jiao Tong University School of Medicine
CTC
Comprehensive Cancer Centers of Nevada
Expression of Tumor Markers in Circulating Tumor Cells of Metastatic Hormone-sensitive Prostate Cancer
Fudan University
Osteoporosis
Odense University Hospital